Virtus ETF Advisers’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-632
| Closed | -$58K | – | 453 |
|
|
2022
Q1 | $58K | Sell |
632
-37
| -6% | -$3.4K | 0.03% | 361 |
|
|
2021
Q4 | $149K | Buy |
669
+59
| +10% | +$13.1K | 0.06% | 351 |
|
|
2021
Q3 | $211K | Sell |
610
-32
| -5% | -$11.1K | 0.09% | 259 |
|
|
2021
Q2 | $241K | Sell |
642
-604
| -48% | -$227K | 0.1% | 221 |
|
|
2021
Q1 | $387K | Buy |
1,246
+21
| +2% | +$6.52K | 0.16% | 189 |
|
|
2020
Q4 | $306K | Sell |
1,225
-148
| -11% | -$37K | 0.13% | 203 |
|
|
2020
Q3 | $254K | Sell |
1,373
-188
| -12% | -$34.8K | 0.13% | 259 |
|
|
2020
Q2 | $390K | Buy |
1,561
+396
| +34% | +$98.9K | 0.18% | 208 |
|
|
2020
Q1 | $211K | Sell |
1,165
-170
| -13% | -$30.8K | 0.09% | 274 |
|
|
2019
Q4 | $556K | Buy |
+1,335
| New | +$556K | 0.09% | 197 |
|